コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y) for 30 days or LHRH antagonist Cetrorelix pamoate (100 microg/day) for 30 days and daily injection
2 mpounds identified in this screen: pyrvinium pamoate, a Food and Drug Administration-approved drug, a
4 ection was significantly higher with oxantel pamoate-albendazole than with mebendazole (31.2% vs. 11.
5 d the efficacy and safety profile of oxantel pamoate-albendazole when used in the treatment of T. tri
6 s drugs, such as the antihelminthics oxantel pamoate and pyrantel pamoate; the psychoactive compounds
7 h-throughput screen and identified pyrvinium pamoate as a drug-promoting exon inclusion without editi
8 , to receive one of four treatments: oxantel pamoate at a dose of 20 mg per kilogram of body weight,
9 e, administered on consecutive days; oxantel pamoate at a single dose of 20 mg per kilogram; albendaz
11 hroism spectroscopy indicates that pyrvinium pamoate binds directly to the pre-mRNA and changes its s
12 dministration of the CK1 activator pyrvinium pamoate by in vivo injection immediately after ischemia
17 Genome-wide analyses show that pyrvinium pamoate regulates >300 alternative exons that form secon
21 antihelminthics oxantel pamoate and pyrantel pamoate; the psychoactive compounds hydroxyzine pamoate
22 ydroxyzine pamoate (Vistaril) and imipramine pamoate (Tofranil-PM); and the peptide hormones triptore
23 il-PM); and the peptide hormones triptorelin pamoate (Trelstar) and octreotide pamoate (OncoLar).
24 oate; the psychoactive compounds hydroxyzine pamoate (Vistaril) and imipramine pamoate (Tofranil-PM);
25 cancer and anthelminthic compound, pyrvinium pamoate, which has also been proposed to exert its actio
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。